Good Morning Coffee Friends!  
This morning I've been on the go and too busy to read much news or check   accounts, but I did some research that had been done on the Covid vaccines - in which the one released and approved by India never went through stage III testing - but they decided they were a little behind the ball with the US and UK and China so they approved it anyway.  

"The approval of a vaccine without phase III data is “unconscionable,” says Vineeta Bal, an immunologist at India’s National Institute of Immunology. It also seems to ignore guidelines from the Central Drugs Standard Control Organisation (CDSCO), the authority helmed by Somani, which stipulate that vaccine makers must show a minimum efficacy of 50% in a phase III trial for their vaccines to be approved, says Gagandeep Kang, a microbiologist at the Christian Medical College in Vellore and a board member of the Coalition for Epidemic Preparedness Innovations. “They provided the guidance and then went against their own guidance,” Kang says “I don’t know what made them do this.”


FYI:   The AstraZeneca-Oxford vaccine, produced by the Serum Institute of India (SII) under the name Covishield

Another issue that is being debated is that now that the UK is 10-14 days into their vaccinations, the 2nd newer strain of Covid is running rampant for infection.  Hmmm.  You can look up that and ponder if it you wish.







No comments:

Post a Comment

Thanks for sharing morning coffee with me!